https://www.avient.com/investor-center/news/avient-hold-third-quarter-2024-conference-call
Avient
Avient
Avient's
https://www.avient.com/investor-center/news/avient-announces-fourteenth-consecutive-annual-dividend-increase
Avient Corporation
Avient
Avient
https://www.avient.com/investor-center/news/avient-hold-third-quarter-2022-conference-call
Avient
Avient
Avient's
https://www.avient.com/investor-center/news/avient-hold-fourth-quarter-2024-conference-call
Avient Corporation
Avient
Avient's
https://www.avient.com/news/avient-announces-new-eco-conscious-flexible-option-liquid-metering
About Avient
Avient Announces Quarterly Dividend...
Avient Board of Directors Appoints Ashish K.
https://www.avient.com/sites/default/files/2020-10/colormatrix-reprize-for-rpet-brochure.pdf
ColorMatrix™ rePrize™ is a patent-
protected, liquid formulation IV builder
designed for addition to the extrusion process
during the manufacture of rPET.
Avient makes no warranties or
guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
You have the responsibility to conduct full-scale end-product performance testing
to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
https://www.avient.com/sites/default/files/2023-03/Cesa Nox A4R Product Bulletin_0.pdf
Avient makes no warranties or guarantees
respecting suitability of either Avient’s products or the information for your process or end-use application.
You have the responsibility to conduct full-scale end-product performance testing to determine
suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
AVIENT MAKES NO WARRANTIES, EXPRESS OR IMPLIED,
INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, either with respect to the information or products reflected by the information.
https://www.avient.com/resource-center?document_subtype=0&document_type=59&form_id=resource_filter_form&industry=0&op=FILTER RESULTS&product_family=0&product_name=0&page=46
Avient Resources
Avient Resources
Versaflex™ PF formulations are specially developed for the manufacture of co-extruded surface protective films (Chinese language version)
https://www.avient.com/resource-center?document_type=59&page=46
Avient Resources
Avient Resources
Versaflex™ PF formulations are specially developed for the manufacture of co-extruded surface protective films (Chinese language version)
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520PolyOne%2520Distribution.pdf
Schuering
Page 77
Appliance
5%
Building &
Construction
3% Wire & Cable
Electrical &
Electronics
Consumer
21%
Industrial
24%
HealthCare
21%
Transportation
17%
2011 Revenue: $1.0 Billion2011 Revenue: $1.0 Billion Key SuppliersKey Suppliers
At a Glance
Packaging
2.6% 3.0%
3.5%
4.0% 4.6%
5.6%
2006 2007 2008 2009 2010 2011 2015
Operating Income % of Sales
ROICROIC Expanding ProfitsExpanding Profits
15.3%
18.4%
22.4%
30.0%
39.2%
48.6%
2006 2007 2008 2009 2010 2011
Target
6 – 7.5%
Page 78
Value Proposition and Transformation Highlights
Value Proposition
• North America-based distributor with expanding global reach providing
key plastic processors and market segments with best-in-class suppliers
products, service and delivery with a commitment to develop value-added
solutions to enhance customer profitability
Transformation Highlights
• Significant market share gains with key suppliers
,
> $5B Addressable Market
• Significant market share gains with key suppliers
� Proprietary PolyOne technology
� Dow Corning
• Improved sales mix and profitability by shifting to
non-cyclical businesses like healthcare
• Established presence in Brazil and Asia in 2011
Page 79
Key Differentiators
• Product offering
� Breadth and depth; industry leading suppliers
• Sales and marketing capability
• Customer service / logistics operations
� Customer survey results – consistent best-in-class performance
� Leading on-time delivery
• Management team experience and stability
• Lean Six Sigma
� Solving our customers’ unmet needs
Page 80
$102.8
$207.2
Healthcare Revenue
• Strong market segmentation
provides focused resourcing
to accelerate growth
• Expanding global reach meets
Areas of Focus
$66.0
$182.4
National Accounts Revenue
• Expanding global reach meets
customers’ needs and creates
competitive differentiation
• Selling skills & product
application knowledge to
target executives & engineers
($ millions)
Page 81
Critical Imperatives
• Invest in commercial resources to accelerate growth
• Expand healthcare and key account revenues
• Broaden geographic reach and develop new markets and
channel partnerships
Critical Imperatives and 2015 Goal
channel partnerships
• Continue to improve working capital efficiency
and superior cash flow generation
2015 Goal
• 6 - 7.5% return on sales
Page 82
Page 83